Successful Clinical Equipment Supplied In Austria
1 equipment items found
Manufactured by:OncoQR ML GmbH based inBreitenfurt, AUSTRIA
Lead candidate OQR200 is a new candidate against HER2/neu, the by far best characterized and clinically validated target to treat breast cancer indications. A reversible induction of HER2/neu specific antibodies has been demonstrated. In vitro, the immune response induced by OQR200 has been shown to have superior efficacy in a direct side by side comparison with ...